Wegovy
Brand semaglutide (Novo Nordisk)
FDA-approved semaglutide for chronic weight management.
About Wegovy
Wegovy is approved for adults and children 12 and older with obesity, or overweight with a weight-related condition, along with diet and exercise. It is also approved to lower the risk of heart attack and stroke in adults with heart disease and obesity or overweight. In the STEP 1 trial, adults lost about 15% of body weight over 68 weeks.
Read the full Semaglutide guide: research, safety and sources →
How it works
- Complete a short online visit. Answer health questions on our telehealth partner's secure site. Some treatments need lab work first.
- A licensed provider reviews it. They decide whether Wegovy is safe and appropriate for you and may message you with questions.
- If prescribed, it ships to you from a licensed U.S. pharmacy, with ongoing check-ins and refills through your provider.
Important safety information
Carries a boxed warning: in rodents it caused thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Nausea, vomiting, diarrhea and constipation are common. Pancreatitis, gallbladder problems, kidney problems and low blood sugar (with other diabetes medicines) can occur. Not for use during pregnancy.
This is not a complete list. Your provider will review your health history, medicines and allergies before prescribing, and the pharmacy includes the full prescribing information.